Share on LinkedInShare on LinkedIn

ARTICLE · 23 AUGUST 2017

Federal Circuit Patent Updates - August 2017

WilmerHale
WilmerHale
Contributor
WilmerHale

WilmerHale

WilmerHale's London office was established more than 40 years ago. With lawyers qualified in the...

View firm profile
Explore more from WilmerHale

Federal Circuit Patent Updates - August 2017

United StatesIntellectual Property

View previous updates...

Amgen Inc. v. Hospira, Inc. (No. 2016-2179, 8/10/17) (Dyk, Bryson, Chen)

August 10, 2017 6:08 PM

Dyk, J. Amgen sought review of a discovery order in an action under the Biologics Price Competition and Innovation Act of 2009 ("BPCIA") that information did not have to be disclosed related to patents not in suit but which Amgen claimed should have been provided as part of the information exchange required by the BPCIA. The Federal Circuit held it lacked jurisdiction over the discovery order under the collateral order doctrine and that the conditions for mandamus were not satisfied.

A full version of the text is available in PDF form.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from